Abstract
Aims
Juvenile idiopathic arthritis (JIA) is often associated with severe chronic anterior uveitis (CAU), and immunosuppressive therapy may be required. In this study, the value of cyclosporine A (CsA) as monotherapy or as combination therapy for treating uveitis was studied in a large cohort of JIA children.
Methods
Multicentre retrospective study including 82 JIA children (girls n=60) suffering from unilateral or bilateral (n=55) CAU. The indication for CsA was active uveitis, although patients were on topical or systemic corticosteroids, MTX, or other immunosuppressive drugs.
Results
Inactivity of uveitis during the entire treatment period (mean 3.9 years) was obtained with CsA monotherapy in 6 of 25 (24%) patients, but more often when CsA was combined with the immunosuppressives (35/72 patients; 48.6%, P=0.037), or MTX (18/37 patients, 48.6%, P=0.065), which had already been given. With CsA (mean dosage 2.9 mg/kg), systemic immunosuppressive drugs and steroids could be reduced by ⩾50% (n=19) or topical steroids reduced to ⩽2 drops/eye/day (n=40) in selected patients. Pre-existing cystoid macular oedema did not resolve under CsA treatment in any of the patients. In nine patients (11%), CsA was discontinued because of systemic hypertension (n=1), elevated creatinine levels (n=3), or other adverse effects (n=5).
Conclusions
These observations suggest that CsA has limited value as a second-line immunosuppressive drug for the treatment of JIA-associated CAU. The efficacy was better as the combination therapy in patients not responding to other immunosuppressives (eg, MTX) than the systemic monotherapy.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Mingels A, Hudde T, Heinz C, Heiligenhaus A . Vision-threatening complications in childhood uveitis. Ophthalmologe 2005; 102: 477–484.
Andersson Gare B . Juvenile arthritis—who gets it, where and when? A review of current data on incidence and prevalence. Clin Exp Rheumatol 1999; 17: 367–374.
Manners PJ, Bower C . World-wide prevalence of juvenile arthritis why does it vary so much? J Rheumatol 2002; 29: 1520–1530.
Carvounis PE, Herman DC, Cha S, Burke JP . Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature. Graefes Arch Clin Exp Ophthalmol 2006; 244: 281–290.
Heiligenhaus A, Niewerth M, Mingels A, Ganser G, Thon A, Pleyer U et al. Epidemiology of uveitis in juvenile idiopathic arthritis from a national paediatric rheumatologic and ophthalmologic database. Klin Monatsbl Augenheilkd 2005; 222: 993–1001.
Edelsten C, Lee V, Bentley CR, Kanski JJ, Graham EM . An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol 2002; 86: 51–56.
Paroli MP, Speranza S, Marino M, Pirraglia MP, Pivetti-Pezzi P . Prognosis of juvenile rheumatoid arthritis-associated uveitis. Eur J Ophthalmol 2003; 13: 616–621.
Kilmartin DJ, Forrester JV, Dick AD . Cyclosporin A therapy in refractory non-infectious childhood uveitis. Br J Ophthalmol 1998; 82: 737–742.
Kotaniemi K . Late onset uveitis in juvenile-type chronic polyarthritis controlled with prednisolone, cyclosporin A and methotrexate. Clin Exp Rheumatol 1998; 16: 469–471.
Gerloni V, Cimaz R, Gattinara M, Arnoldi C, Pontikaki I, Fantini F . Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis. Results of a 10-year prospective study. Rheumatology (Oxford) 2001; 40: 907–913.
Feutren G, Mihatsch MJ . Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases. N Engl J Med 1992; 326: 1654–1660.
Walton RC, Nussenblatt RB, Whitcup SM . Cyclosporine therapy for severe sight threatening uveitis in children and adolescents. Ophthalmology 1998; 105: 2028–2034.
Jabs DA, Nussenblatt RB, Rosenbaum JT . Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 2005; 140: 509–516.
Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, edmonton 2001. J Rheumatol 2004; 31: 390–392.
Brooks P, Hochberg M . Outcome measures and classification criteria for the rheumatic diseases. A compilation of data from OMERACT (Outcome Measures for Arthritis Clinical Trials), ILAR (International League of Associations for Rheumatology), regional leagues and other groups. Rheumatology (Oxford) 2001; 40: 896–906.
Saurenmann RK, Levin AV, Rose JB, Parker S, Rabinovitch T, Tyrrell PN et al. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. Rheumatology (Oxford) 2006; 45: 982–989.
Towler HM, Cliffe AM, Whiting PH, Forrester JV . Low-dose cyclosporin A therapy in chronic posterior uveitis. Eye 1989; 3: 282–287.
Vitale AT, Rodriguez A, Foster CS . Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis. Ophthalmology 1996; 103: 365–373; discussion 373–374.
Schlote T, Dannecker G, Thiel HJ, Zierhut M . Cyclosporin A in therapy of chronic uveitis in childhood. Ophthalmologe 1996; 93: 745–748.
Hoyer PF, Offner G, Oemar BS, Brodehl J, Ringe B, Pichlmayr R . Four years' experience with cyclosporin A in pediatric kidney transplantation. Acta Paediatr Scand 1990; 79: 622–629.
Tugwell P . International consensus recommendations on cyclosporin use in rheumatoid arthritis. Drugs 1995; 50: 48–56.
Author information
Authors and Affiliations
Corresponding author
Additional information
Financial/proprietary interest: None
Rights and permissions
About this article
Cite this article
Tappeiner, C., Roesel, M., Heinz, C. et al. Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis. Eye 23, 1192–1198 (2009). https://doi.org/10.1038/eye.2008.174
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2008.174
Keywords
This article is cited by
-
Diagnosis and Management of Non-Infectious Uveitis in Pediatric Patients
Pediatric Drugs (2024)
-
Juvenile Uveitis
Spektrum der Augenheilkunde (2024)
-
Update on the Treatment of Uveitis in Patients with Juvenile Idiopathic Arthritis: A Review
Advances in Therapy (2017)
-
An Update on Treatment of Pediatric Chronic Non-infectious Uveitis
Current Treatment Options in Rheumatology (2017)
